Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Specialist Microplate Products for Life Sciences

Published: Wednesday, February 12, 2014
Last Updated: Wednesday, February 12, 2014
Bookmark and Share
Porvair will be showing its microplate equipment at the forthcoming Pittcon 2014, Analytica 2014 and Genomics Research 2014 exhibitions.

Porvair Sciences has announced that it will be showing its latest specialist microplates and microplate equipment at the forthcoming Pittcon 2014 (Chicago), Analytica 2014 (Munich) and Genomics Research 2014 (San Francisco) exhibitions.

Visitors to Pittcon Booth 4021 and Analytica Stand B2.320A will be able to see Porvair’s complete range of automation friendly microplates and equipment. On display will be the Ultravap Mistral - Porvair's new generation robot-compatible nitrogen blow down station.

For many years, Porvair Sciences has led the field in nitrogen blow down evaporation. The UltraVap Mistral makes it even easier to integrate an automatic dry down step into users automated liquid handling protocol.

Combining uncompromising high quality with an affordable price - Porvair Sciences will also display its extensive range of reagent reservoirs, robotic manifolds together with deep well, shallow well, storage, assay, SPE, protein precipitation and filtration microplates precisely manufactured to comply with ANSI/SLAS dimensions.

Visitors to Genomics Research 2014 Booth 17 will have the opportunity to see and discuss with applications experts – Porvair’s growing range of novel solid state ChromaTrap® Chromatin immunoprecipitation (ChIP) assay products.

At this meeting - Porvair will launch the new Chromatrap® HT96 high throughput ChIP assay plate. Developments in the field of epigenetics are rapidly expanding as researchers elucidate the principles governing gene regulation through the in vivo dynamic binding of proteins to DNA.

Key to this is the need to analyze large numbers of high and low abundant regulatory mechanisms to systematically map protein-DNA interactions following pathogen/disease stimulus.

Enabling up to 96 ChIP assays to be run in parallel on the same plate the Chromatrap® HT96 offers epigenetic researchers many benefits including multiple target screening, flexible experimental design, robust reproducibility, high data quality and automated liquid handling potential.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Porvair Filtration Group Receives Queen’s Award for Enterprise in International Trade
This award had been made in recognition of Porvair’s substantial growth in overseas business, achieving increased year-on-year growth in sales of exported products over the past three years.
Tuesday, April 21, 2015
Study Investigates Inherent Contamination in Deep Well Microplates
Study gives data on microplates from numerous manufacturers based in Europe, USA and China.
Tuesday, October 21, 2014
Reference Guide to Microplate Chemical Compatibility
Porvair’s new version of chemical compatibility chart.
Wednesday, August 14, 2013
Porvair Sciences Launches www.microplates.com
New website designed to offer a wide variety of useful information about microplates or microplate technologies.
Thursday, July 16, 2009
Porvair Sciences Invests in new Microplate Production Facility
Porvair Sciences has announced the opening of a new Class 10000 cleanroom at their Wrexham, UK facility.
Tuesday, October 09, 2007
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!